Saluda Medical, Inc. (ASX:SLD)
Australia flag Australia · Delayed Price · Currency is AUD
0.6000
-0.0200 (-3.23%)
At close: Aug 12, 2026

Saluda Medical Financials Overview

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Jun '25 Jun '24 Jun '23
Revenue
76.0770.3651.6822.23
Revenue Growth
242.12%36.13%132.45%-
Gross Profit
36.3132.7623.114.04
Operating Income
-129.46-118.05-99.14-92.22
Net Income
-252.65-149.3-97.83-92.16
Earnings Per Share
-6.56-45.92-30.13-28.40
EPS Growth
----

Revenue by Geography

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Jun '25 Jun '24 Jun '23
United States
53.2649.8832.96.48
Australia
5.75.297.054.72
Germany
-5.364.173.48
Netherlands
-3.942.843.49
United Kingdom
-32.583.13
Other
-2.892.150.94
Total
76.0770.3651.6822.23

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingDec '25 Jun '25 Jun '24 Jun '23
Cash & Investments
151.4354.571.79166.74
Total Debt
75.08205.1271.7967.39
Net Cash (Debt)
76.34-150.620.0199.35
Net Cash Growth
-23.16%--99.99%-
Net Cash Per Share
1.98-46.320.0030.62

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Jun '25 Jun '24 Jun '23
Operating Cash Flow
-120.84-118.24-93.32-85.66
Capital Expenditures
-1.24-1.27-1.08-2.37
Free Cash Flow
-122.08-119.51-94.4-88.03
Free Cash Flow Growth
----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Jun '25 Jun '24 Jun '23
Gross Margin
47.73%46.56%44.72%18.17%
Operating Margin
-170.20%-167.79%-191.82%-414.78%
Pretax Margin
-212.78%-211.46%-188.76%-411.76%
Profit Margin
-332.14%-212.21%-189.29%-414.52%
FCF Margin
-160.49%-169.87%-182.66%-395.93%